Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion type Assertion NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_head.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion evidence source_evidence_literature NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion SIO_000772 16645590 NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion wasDerivedFrom befree-2016 NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.
- NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion wasGeneratedBy ECO_0000203 NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.